https://www.selleckchem.com/pr....oducts/tiragolumab-a
uary 2018; April 2019. Clinical Trial Registration (CTR) Number EUPAS23075. Trial Register Date March 12, 2018. First patient visit; Last patient visit February 2018; April 2019. Despite recent advances in the drug discovery field, developing selective kinase inhibitors remains a complicated issue for a number of reasons, one of which is that there are striking structural similarities in the ATP-binding pockets of kinases. To address this problem, we have designed a machine learning model utilizing various structure-based
Like
Comment
Share